Accuracy of Tumour-Associated Circulating Endothelial Cells as a Screening Biomarker for Clinically Significant Prostate Cancer

Even though more than 350,000 men die from prostate cancer every year, broad-based screening for the disease remains a controversial topic. Guidelines demand that the only commonly accepted screening tool, prostate-specific antigen (PSA) testing, must be followed by prostate biopsy if results are el...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhakdi, Sebastian Chakrit, Suriyaphol, Prapat, Thaicharoen, Ponpan, Grote, Sebastian Tobias Karl, Komoltri, Chulaluk, Chaiyaprasithi, Bansithi, Charnkaew, Komgrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721410/
https://www.ncbi.nlm.nih.gov/pubmed/31357651
http://dx.doi.org/10.3390/cancers11081064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721410/
https://www.ncbi.nlm.nih.gov/pubmed/31357651
http://dx.doi.org/10.3390/cancers11081064

Ejemplares similares